Potentiation of Inhibition of Wild-Type and Mutant Human Immunodeficiency Virus Type 1 Reverse Transcriptases by Combinations of Nonnucleoside Inhibitors and d- and l-(β)-Dideoxynucleoside Triphosphate Analogs

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2001-04, Vol.45 (4), p.1192-1200
Hauptverfasser:	MAGA, Giovanni, HÜBSCHER, Ulrich, PREGNOLATO, Massimo, UBIALI, Daniela, GOSSELIN, Gilles, SPADARI, Silvio
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents Anti-HIV Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral Agents Benzoxazines Biological and medical sciences dideoxynucleoside triphosphate Dideoxynucleosides Dideoxynucleosides - pharmacology Dideoxynucleotides DNA Replication - drug effects DNA, Viral - drug effects Dose-Response Relationship, Drug Drug Resistance, Microbial Drug Synergism HIV Reverse Transcriptase HIV Reverse Transcriptase - antagonists & inhibitors HIV Reverse Transcriptase - genetics Human immunodeficiency virus 1 Humans Inhibitory Concentration 50 Medical sciences Mutation Nevirapine - pharmacology nucleoside analogs nucleoside analogues Oxazines - pharmacology Pharmacology. Drug treatments Reverse Transcriptase Inhibitors Reverse Transcriptase Inhibitors - pharmacology RNA-directed DNA polymerase inhibitors (non-nucleoside) Stereoisomerism Thymine Nucleotides - pharmacology Zidovudine - analogs & derivatives Zidovudine - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!